Amicus Therapeutics (NASDAQ:FOLD) reported quarterly sales of $88.10 million which beat the analyst consensus estimate of $86.29 million by 2.09 percent. This is a 7.23 percent increase over sales of $82.15 million the same period last year.
Solo Brands Announces CFO Transition, Reiterates Fiscal 2023 Guidance; Somer Webb Steps Down Will Remain With The Company Until December 10, 2023; Andrea Tarbox Will Assume The Role Of Interim CFO
Reiterates Fiscal 2023 GuidanceCFO TransitionSolo Brands, Inc. (NYSE:DTC) ("Solo Brands" or "the Company") an omni-channel platform of beloved brands Solo Stove, Chubbies, Oru Kayak, ISLE, and Icy Breeze today announced
